We are live on ! Find out more
LCG

Lisanti Capital Growth Portfolio holdings

AUM $397M
1-Year Est. Return 178.66%
This Fund
S&P 500
This Quarter Est. Return
-8.6%
1 Year Est. Return
+178.66%
3 Year Est. Return
+1,089.72%
5 Year Est. Return
+3,176.57%
10 Year Est. Return
+120,936.2%
AUM
$736M
AUM Growth
-$154M
Cap. Flow
-$53.9M
Cap. Flow %
-7.32%
Top 10 Hldgs %
22.86%
Holding
152
New
40
Increased
35
Reduced
25
Closed
52

Top Buys

Rank Stock Value
1
HALO icon
Halozyme
HALO
+$15.2M
2
HURN icon
Huron Consulting
HURN
+$14.2M
3
HRMY icon
Harmony Biosciences
HRMY
+$13.7M
4
AIT icon
Applied Industrial Technologies
AIT
+$13.1M
5
OLLI icon
Ollie's Bargain Outlet
OLLI
+$11.6M

Top Sells

Rank Stock Value
1
MXL icon
MaxLinear
MXL
+$18.3M
2
FRPT icon
Freshpet
FRPT
+$13.4M
3
RRR icon
Red Rock Resorts
RRR
+$12.9M
4
COHR icon
Coherent
COHR
+$12.7M
5
FORM icon
FormFactor
FORM
+$12.4M

Sector Composition

Rank Sector Weight
1 Healthcare 32.88%
2 Technology 23.88%
3 Industrials 20.04%
4 Consumer Staples 6.39%
5 Consumer Discretionary 5.32%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SBNY
151
DELISTED
Signature Bank
SBNY
– –
-14,750
Closed -$4.33M
BHVN
152
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
– –
-75,947
Closed -$9.01M
3 4 5 6
7

Similar funds

PIM
Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return
EH
EMG Holdings Old Greenwich, Connecticut $397M AUM 9.97% 1-Year Est. Return
TPWA
Twin Peaks Wealth Advisors Burlingame, California $397M AUM 23.23% 1-Year Est. Return
STT
Singapore Technologies Telemedia Singapore $396M AUM 59.06% 1-Year Est. Return
VC
Vision Capital Toronto, Ontario, Canada $397M AUM 0.8% 1-Year Est. Return
CF
Cypress Funds Los Angeles, California $398M AUM 8.77% 1-Year Est. Return
IVLAV
Index Venture Life Associates VI St. Helier, Jersey $396M AUM 176.22% 1-Year Est. Return
MHC
May Hill Capital Cohasset, Massachusetts $398M AUM 23.9% 1-Year Est. Return

Lisanti Capital Growth's Q2 2022 Portfolio in Review

As of Q2 2022, Lisanti Capital Growth held 152 positions worth $736M, down 17% from $890M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Lisanti Capital Growth withdrew a net $53.9M in Q2 2022, closing 52 positions and reducing 25 holdings. Its most notable exit was MaxLinear, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 33% of assets, up from 29% a quarter earlier, followed by Technology and Industrials.

Against the trend, Lisanti Capital Growth opened a new position in Halozyme worth $15.4M.

  • Lisanti Capital Growth's largest Q2 2022 buy was Halozyme: 350,935 shares worth $15.4M.
  • Lisanti Capital Growth added most to GitLab in Q2 2022, an estimated $10.2M increase.
  • Lisanti Capital Growth's biggest Q2 2022 reduction was Pacira BioSciences, cutting an estimated $11.2M.
  • Lisanti Capital Growth fully exited MaxLinear in Q2 2022, selling an estimated $18.3M.
  • Lisanti Capital Growth's ten largest holdings make up 23% of its $736M portfolio in Q2 2022.
  • Lisanti Capital Growth opened 40 new positions and closed 52 in Q2 2022.
  • Lisanti Capital Growth's portfolio value fell 17% quarter-over-quarter to $736M.

Based on Lisanti Capital Growth's 13F filing for Q2 2022, filed 3 Aug 2022.